Lv2
180 积分 2021-10-21 加入
Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial
3天前
已完结
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
18天前
已完结
A randomised phase II trial of 1month versus 1year of adjuvant high-dose interferon α-2b in high-risk acral melanoma patients
20天前
已完结
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
24天前
已完结
Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma
28天前
已完结
Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype
1个月前
已关闭
Efficacy of immune checkpoint inhibitors in advanced mucosal melanoma: A systematic review and meta-analysis
5个月前
已关闭
Mucosal Melanoma: Review from a Pathologist Point of View
5个月前
已完结
Progression-free survival by local investigator versus independent central review: Comparative analysis of the AGO-OVAR16 Trial
10个月前
已完结
Blinded independent central review of progression in cancer clinical trials: Results from a meta-analysis
10个月前
已完结
皖公网安备34019202002308
